Skip to main content
Premium Trial:

Request an Annual Quote

Gillian Small, Greg Tronto, Lorraine Keller, Maureen O’Leary

Premium
The City University of New York has appointed Gillian Small as vice chancellor of research.
 
Small’s responsibilities will include planning new facilities as part of CUNY’s “Decade of Science” initiative, such as the development of the CUNY-wide Advanced Science Research Center, to be located on the campus of City College in the borough of Manhattan.
 
Small will also be responsible for recruiting research faculty and supporting CUNY faculty in planning research programs and obtaining funding. She will also manage a postdoctoral fellowship program, oversee intellectual property and commercialization of CUNY research, and enhance CUNY’s contribution to New York City’s economic development.
 
Small joined CUNY in 2001 as associate dean for research and has served as CUNY’s dean of research since 2003. She has also conducted postdoctoral research at Rockefeller University, and has served on the faculty at the University of Florida and Mount Sinai School of Medicine in New York. She holds a PhD in biology from the University of Wolverhampton in England.
 

 
Greg Tronto, business leader for single-use bioprocess components at the Gore PharmBIO Products unit of medical device maker WL Gore and Associates, has been named a director of the Delaware BioScience Association.
 
Tronto joined WL Gore in 1988. He holds a BS degree in mechanical engineering from Widener University.
 
Established in 2006, the Delaware BioScience Association is a non-profit trade group that works to advance the bioscience industry in Delaware and the Mid-Atlantic region.
 

 
BioStrategy Partners, a virtual incubator that offers technology and business development services to emerging-stage life science companies in the greater Philadelphia area, has named Lorraine Keller as portfolio manager for its corporate development program, and Maureen O’Leary as program director for the its due diligence program.
 
Keller was co-founder and executive vice president of biotech company Immunotope, co-founder and vice president of marketing and communication for RheoGene, and a founding member of the scientific advisory board of BioStrategy Partners.
 
Keller holds a BA in biological sciences from Smith College, and a PhD in plant physiology and molecular biology from Cornell University.
 
O’Leary helped launch 15 startup companies as director of start-up business development at the University of Pennsylvania’s Center for Technology Transfer. During her 10-year career, O’Leary has had primary responsibility for over 200 technology transfer agreements, BioStrategy said.
 
O’Leary holds a BA from Wellesley College and a PhD in physics from the University of Pennsylvania.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.